Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LYMPHOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05135858
What this trial is testing

Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Assistance Publique - Hôpitaux de Paris 18
Large-scale testing (Phase 3)Not Yet RecruitingNCT07072585
What this trial is testing

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

Who this might be right for
Stage II T Lymphoblastic Leukemia/LymphomaStage III T Lymphoblastic Leukemia/LymphomaStage IV T Lymphoblastic Leukemia/Lymphoma+2 more
Children's Oncology Group 1,708
Early research (Phase 1)Not Yet RecruitingNCT07367685
What this trial is testing

Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma

Who this might be right for
Recurrent/Refractory B-cell Lymphoma
The Second Affiliated Hospital of Fujian Medical University 6
Testing effectiveness (Phase 2)UnknownNCT03389815
What this trial is testing

A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients

Who this might be right for
Advanced Solid Tumor, Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 48
Post-approval studies (Phase 4)UnknownNCT02992834
What this trial is testing

Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma

Who this might be right for
Lymphoma, B Cell
jiangjingting 10
Testing effectiveness (Phase 2)Ended earlyNCT01090414
What this trial is testing

An Extension Study for Subjects Who Are Deriving Benefit With Idelalisib (GS-1101; CAL-101) Following Completion of a Prior Idelalisib Study

Who this might be right for
Chronic Lymphocytic LeukemiaLymphoma, Non-Hodgkin
Gilead Sciences 202
Early research (Phase 1)Ended earlyNCT03220347
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinNeoplasms
Celgene 139
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07768943
What this trial is testing

GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell Lymphoma

Who this might be right for
Natural Killer/T-cell Lymphoma
Fudan University 620
Testing effectiveness (Phase 2)Study completedNCT00003335
What this trial is testing

Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Case Comprehensive Cancer Center 44
Early research (Phase 1)Study completedNCT00006221
What this trial is testing

BMS-247550 in Treating Patients With Advanced Cancers

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 54
Early research (Phase 1)Study completedNCT05225584
What this trial is testing

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

Who this might be right for
Non Hodgkin Lymphoma (NHL)Peripheral T-cell Lymphoma (PTCL)Cutaneous T-Cell Lymphoma (CTCL)+3 more
Kymera Therapeutics, Inc. 56
Early research (Phase 1)Active Not RecruitingNCT05878184
What this trial is testing

Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)

Who this might be right for
Non Hodgkin LymphomaChronic Lymphocytic Leukemia
Sana Biotechnology 16
Early research (Phase 1)Study completedNCT03013933
What this trial is testing

Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Recurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma
City of Hope Medical Center 29
Not applicableStudy completedNCT00330538
What this trial is testing

Osteoporosis in Children With ALL

Who this might be right for
Leukemia, Lymphocytic, Acute, L1
Children's Mercy Hospital Kansas City 20
Early research (Phase 1)Study completedNCT00992758
What this trial is testing

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 11
Large-scale testing (Phase 3)Study completedNCT02684708
What this trial is testing

Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents

Who this might be right for
Classical Hodgkin Lymphoma
University of Giessen 2,921
Not applicableUnknownNCT02520908
What this trial is testing

Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis

Who this might be right for
Epidermotropic T-cell Lymphomas
Assistance Publique - Hôpitaux de Paris 98
Testing effectiveness (Phase 2)Study completedNCT00290433
What this trial is testing

Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT02927964
What this trial is testing

TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma

Who this might be right for
Grade 1 Follicular LymphomaGrade 2 Follicular LymphomaGrade 3a Follicular Lymphoma+4 more
Robert Lowsky 21
Testing effectiveness (Phase 2)Study completedNCT04660799
What this trial is testing

A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, in Combination With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) in Previously Untreated Participants With CD20 Positive Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Hoffmann-La Roche 50
Next Page